載入...
Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
Choroidal neovascularization (CNV) secondary to pathologic myopia has a very high incidence in global, especially in Asian, populations. It is a common cause of irreversible central vision loss, and severely affects the quality of life in the patients with pathologic myopia. The traditional therapeu...
Na minha lista:
| 發表在: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494177/ https://ncbi.nlm.nih.gov/pubmed/26170626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S87920 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|